Five years ago, AlphaFold 2 cracked a 50-year-old biological puzzle at the CASP 14 competition, predicting protein structures from amino acid sequences with accuracy that stunned the scientific community. Google DeepMind's breakthrough earned the 2024 Nobel Prize in Chemistry, validating AI as a powerful tool for advancing fundamental science. What was once a monumental experimental task taking years now takes seconds.

The AlphaFold Protein Database, launched with EMBL-EBI in 2021, contains predictions for over 200 million protein structures. More than 3 million researchers across 190 countries use the freely available database, including over 1 million in low- and middle-income countries. An independent analysis shows researchers using AlphaFold 2 see a 40% increase in novel experimental protein structure submissions, and AlphaFold-linked research is twice as likely to be cited in clinical articles.

The practical applications are already reshaping multiple fields. Scientists used AlphaFold to decode a key immunity protein in honeybees, guiding conservation efforts for endangered populations. Researchers finally revealed the structure of apolipoprotein B100, the central protein in heart disease, giving pharmaceutical companies the atomic-level blueprint needed to design new preventative therapies. Turkish undergraduate students taught themselves structural biology through online tutorials and have published 15 research papers.

AlphaFold 3, developed with drug discovery company Isomorphic Labs, now predicts interactions between proteins, DNA, RNA, and ligands. The AlphaFold Server has generated over 8 million predictions for researchers worldwide. With over 35,000 citations and counting, the model has become an indispensable tool in the biologist's arsenal.